Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Santarus, Inc. (NASDAQ: SNTS) today reported financial and operating results for the quarter ended June 30, 2013. Key financial results include:
•Total revenues of $89.4 million grew 89% compared with total revenues of $47.2 million in the second quarter of 2012
•Non-GAAP adjusted earnings were $24.3 million and diluted non-GAAP adjusted earnings per share (EPS) were $0.31 in the second quarter of 2013 compared with non-GAAP adjusted earnings of $7.1 million and diluted non-GAAP adjusted EPS of $0.10 for the second quarter of 2012
Hey, check out all the research scientist jobs. Post your resume today!
Santarus, Inc. (NASDAQ: SNTS) today reported financial and operating results for the quarter ended June 30, 2013. Key financial results include:
•Total revenues of $89.4 million grew 89% compared with total revenues of $47.2 million in the second quarter of 2012
•Non-GAAP adjusted earnings were $24.3 million and diluted non-GAAP adjusted earnings per share (EPS) were $0.31 in the second quarter of 2013 compared with non-GAAP adjusted earnings of $7.1 million and diluted non-GAAP adjusted EPS of $0.10 for the second quarter of 2012
Hey, check out all the research scientist jobs. Post your resume today!
